Date post: | 02-Apr-2018 |
Category: |
Documents |
Upload: | micija-cucu |
View: | 217 times |
Download: | 0 times |
of 186
7/27/2019 bradikard
1/186
BradycardiaHighlights
Summary
Overview
Basics
Definition
EpidemiologyAetiology
Pathophysiology
Classification
Prevention
Screening
Secondary
Diagnosis
History & examination
Tests
Differential
Step-by-step
GuidelinesCase history
Treatment
Details
Step-by-step
Guidelines
Follow Up
Recommendations
Complications
Prognosis
Resources
References
Images
Patient leaflets
Credits
Feedback
Share
Add to Portfolio
Bookmark
Add notes
History & exam
Key factors
presence of risk factors
pulse rate below 50 bpm
dizziness/lightheadedness
syncope
fatigue
http://bestpractice.bmj.com/best-practice/monograph/832/highlights.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/summary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/definition.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/epidemiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/aetiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/pathophysiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/classification.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/screening.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/secondary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/differential.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/case-history.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/recommendations.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/complications.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/prognosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/patient-leaflets.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/credits.htmlhttp://bestpractice.bmj.com/best-practice/emailfriend/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/feedback/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/share/832/highlights/overview.htmlhttp://portfolio.bmj.com/portfolio/add-to-portfolio.html?u=%3C;url%3Ehttp://bestpractice.bmj.com/best-practice/mybp/mybpSave.html?category=bookmark&dataKey=Bradycardia+-+Overview&dataValue=%2Fbest-practice%2Fmonograph%2F832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/summary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/definition.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/epidemiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/aetiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/pathophysiology.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/basics/classification.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/screening.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/prevention/secondary.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/differential.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/case-history.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/step-by-step.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/recommendations.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/complications.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/follow-up/prognosis.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/patient-leaflets.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/credits.htmlhttp://bestpractice.bmj.com/best-practice/emailfriend/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/feedback/832/highlights/overview.htmlhttp://bestpractice.bmj.com/best-practice/share/832/highlights/overview.htmlhttp://portfolio.bmj.com/portfolio/add-to-portfolio.html?u=%3C;url%3Ehttp://bestpractice.bmj.com/best-practice/mybp/mybpSave.html?category=bookmark&dataKey=Bradycardia+-+Overview&dataValue=%2Fbest-practice%2Fmonograph%2F832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.html7/27/2019 bradikard
2/186
exercise intolerance
shortness of breath
cannon a-waves in jugular venous pulse
jugular venous distension
Other diagnostic factors
increased intracranial pressure
abnormal heart sounds
abdominal or lower extremity oedema
hypotension
mental status changes
pallor
extremities cool to touch
hypothermia
chest pain
History & exam details
Diagnostic tests
1st tests to order
12-lead ECG
Holter monitoring
event monitor
exercise testing
carotid sinus massage
echocardiogram
thyroid function tests
basic metabolic panel
cardiac markers
serum digoxin level
serum creatinine
Tests to consider
implantable-loop recorder
tilt-table testing
electrophysiology testing
Diagnostic tests details
Treatment details
http://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/history-and-examination.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/tests.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/treatment/details.html7/27/2019 bradikard
3/186
Acute
haemodynamically unstable
pharmacotherapy
temporary pacing
haemodynamically stable: sinus node dysfunction
reversible cause: asymptomatic or mild symptoms
o treatment of underlying cause
o theophylline
reversible cause: severe symptoms
o treatment of underlying cause + temporary pacing
irreversible cause: asymptomatic or mild symptoms
o reassurance
irreversible cause: severe symptoms
o permanent pacing
haemodynamically stable: acquired AV block
reversible cause: asymptomatic without indications for pacing
o treatment of underlying cause
reversible cause: symptomatic or indications for pacing
o treatment of underlying cause + temporary pacing
irreversible cause: asymptomatic without indications for pacing
o reassurance
irreversible cause: symptomatic or indications for pacing
o permanent pacing
hemodynamically stable: congenital AV block
asymptomatic without indications for pacing
o reassurance
symptomatic or indications for pacing
o permanent pacing
haemodynamically stable: vagally mediated bradycardia
carotid hypersensitivity syndrome
o permanent pacing
neurocardiogenic or vasovagal syncope
o lifestyle modifications
7/27/2019 bradikard
4/186
o pharmacotherapy
o permanent pacing
Treatment details
Summary
Any heart rhythm slower than 50 bpm, even if transient, owing to sinus node dysfunction and/or
atrioventricular (AV) conduction abnormalities.
Causes include intrinsic sinus node and AV nodal disease, or extrinsic influences, which may be
reversible.
Common symptoms include syncope, fatigue, and dizziness; however, the patient may be
asymptomatic.
Evaluation involves determining the association of symptoms with heart rate and an assessment of
underlying cardiovascular conditions. ECG is the diagnostic test of choice.
Patients with a reversible cause may not require long-term therapy; however, patients with non-
reversible causes may require an implantable pacemaker with or without a defibrillator. Urgent treatment may
include temporary pacing and drug interventions.
Potentially life-threatening complications, including cardiovascular collapse and death, may occur.
DefinitionWhile some consider bradycardia to be a heart rate
7/27/2019 bradikard
5/186
tissue inflammation or infiltration, infections (e.g., typhoid fever, diphtheria,tuberculosis, toxoplasmosis, rheumatic fever, or viral myocarditis), orabnormal autonomic effects. Extrinsic causes include exposure to toxins(e.g., lead, black widow spider venom, or tricyclic antidepressant overdose),drugs (e.g., digoxin, beta-blockers, calcium-channel blockers, or class I or III
antiarrhythmics), or electrolyte abnormalities.[3] [16]Some causes, such ashypothyroidism, electrolyte disorders, and those that are drug-induced, arereversible. Inferior wall myocardial infarction and increased intracranialpressure can also cause various types of bradycardia.
High vagal tone in an otherwise healthy young adult is a common cause ofsinus bradycardia and Mobitz I (rarely Mobitz II) atrioventricular (AV) block.This may even manifest during sleep and may be exacerbated by sleepapnoea.
Generalised conduction system disease related to calcification and fibrosis iscalled Lev's disease (or Lenegre-Lev syndrome) and is a cause of acquiredcomplete heart block. Lev's disease is seen most commonly in older peopleand is often described as senile degeneration of the conduction system.
PathophysiologyThe cellular mechanisms are complex and interrelated. Failure of any one of these mechanisms can have an
effect on heart rate. Normal cardiac electrical activation requires normal sinus node automaticity and effective
AV node and His-Purkinje conduction. Anything that causes sinus node automaticity or conduction through the
AV node and/or His-Purkinje system can cause bradycardia.
Classification
Clinical classification
Bradycardia can be classified as asymptomatic or symptomatic.Asymptomatic patients often do not require treatment.
Bradycardia classification
Bradycardia can be classified according to the site of the conductiondisturbance.[3]
Sinus node dysfunction
Sinus bradycardia: heart rate below 50 bpm. It can be a normal finding, especially during rest or sleep,
or can be abnormal and symptomatic.[4]
Sinus nodal pauses/arrest: episodic, abrupt termination of sinus rhythm generally lasting longer than 3
seconds. Episodes can last longer than 30 seconds. There can be haemodynamic collapse, loss of blood
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-4http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-16http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-47/27/2019 bradikard
6/186
pressure, and/or loss of consciousness. The term sinus arrest is used generally for long sinus node pauses (i.e.,
>5 seconds).[5]
Sinus nodal exit block: sinus node continues to activate but electrical activation is delayed and either
blocked completely or incompletely between the sinus node and the atria. There can be various levels of block
(e.g., complete or intermittent block).[6]
Tachycardia-bradycardia syndrome: occurs when there are episodic periods of tachycardia (usually
atrial flutter, atrial fibrillation, or atrial tachycardia), followed by termination of the tachycardia leading to sinus
arrest or long sinus pauses, followed by sinus bradycardia.[7]
Chronotropic incompetence: a form of bradycardia in which the sinus rate does not accelerate
appropriately with exercise.[8]
Sick sinus syndrome: a condition in which sinus node dysfunction manifests as one of the above
abnormalities and there is evidence of slowing of sinus node function. Although this is generally not due to
autonomic abnormalities, they can contribute. Some patients have marked bradycardia owing to sinus node
dysfunction only after medicines that slow the sinus node are initiated. Sick sinus syndrome has been associated
with atrioventricular (AV) nodal conduction abnormalities and a high risk of systemic embolism.[9]AV conduction disturbance
AV block occurs when atrial depolarisation fails to reach the ventricles orwhen atrial depolarisation is conducted with a delay.
First-degree AV block: delay in AV conduction, such that the PR interval is over 0.2 seconds. During
first-degree AV block, there is one-to-one conduction but there is delay in AV nodal conduction.[10] It is not
necessarily associated with bradycardia but it may be associated with higher degrees of AV block and
subsequent bradycardia or sinus node dysfunction.
Second-degree AV block: periodic failure of conduction from the atria to the ventricles. This assumes
that the atrial rate is regular. A blocked premature atrial beat is not second-degree AV block. There are different
types:
o Mobitz I: grouped beating with a constant PP interval, lengthening in the PR interval and
changing (usually shortening) RR intervals with the cycle ending with a P-wave and not followed by a QRS
complex. As the PR interval gradually prolongs, the RR interval tends to stay the same or shorten.[11]Also
called Wenckebach AV block.
o Mobitz II: associated with single non-conducted P-waves with a constant PP interval and
constant PR intervals (no change in the PR above 0.025 seconds).[12]
o 2:1 block: only one PR interval to examine before the blocked P-wave and 2 P-waves for every
QRS complex. In most cases, it will change to Mobitz I or II. If there is an associated bundle branch block, this
suggests block in the His-Purkinje system.
o High-degree AV block: more than one sequentially blocked P-wave.[13]
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-13http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-5http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-6http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-7http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-8http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-137/27/2019 bradikard
7/186
Third-degree AV block: occurs when there are no conducted impulses from the atria to the ventricles.
Also called complete AV block. This may occur with regular atrial activity without conduction or with an atrial
tachyarrhythmia.
Paroxysmal AV block: normal AV nodal conduction followed by sudden block of AV conduction
associated with a long pause and multiple blocked P-waves, with subsequent resumption of AV conduction. Thiscan be related to underlying AV nodal or His-Purkinje conduction anomalies or to abrupt parasympathetic
activation causing block in AV nodal conduction. In the latter instance, there is often slowing in sinus activation.
Vagotonic AV block: slowing of the sinus node with prolongation of the PR interval followed by AV block
owing to transient abrupt increase in parasympathetic tone.
Congenital complete heart block: usually associated with a narrow QRS complex escape rhythm arising
in the AV node.
Escape rhythms
When the sinus rate slows or there is AV block, other cardiac structures canactivate owing to their intrinsic automaticity. The AV nodal rate tends to be 40to 60 bpm and the ventricular rate tends to be 20 to 40 bpm.
Atrial rhythm: originates from atrial structures other than the sinus node during sinus bradycardia or
sinus arrest.
Junctional rhythm: escape rhythm when there is bradycardia or arrest of sinus node or atrial activation.
Activation of the junction may occur with or without AV block.[14]
Ventricular rhythm: an escape rhythm from the ventricles when there is AV block or sinus bradycardia.
AV dissociation
Atrial and ventricular activation occur from different pacemakers. Ventricular activation may be from
junctional or infranodal automaticity. AV dissociation can occur in the presence of intact AV conduction,
especially when rates of the pacemaker, either junctional or ventricular, exceed the atrial rate.
The atria and ventricles do not activate in a synchronous fashion but beat independent of each other.
Usually, the ventricular rate is the same or faster than the atrial rate. When the atrial rate is faster and the atria
and ventricles are beating independently, complete heart block is present.
AV dissociation can be complete or incomplete. When incomplete, some P-waves conduct and capture
the ventricles but, if they do not, it is complete. Complete AV dissociation mimics AV block and has to do with P-
wave timing in relation to independent ventricular activation.
There are 2 types
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-14http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-147/27/2019 bradikard
8/186
o Isorhythmic: when the atrial rate is the same (or nearly the same) as the ventricular rate but the
P-wave is not conducted.
o Interference: when P-waves and QRS rates are similar but, occasionally, the atria conduct to the
ventricles.
ScreeningScreening for bradycardia is not carried out normally because treatment is usually administered for symptomatic
patients only.
Patients may present with conditions that potentially predispose to bradycardia during routine clinic visits and
these can be identified easily based on a review of the patient's medical history (e.g., hypothyroidism, medicines,
and history of myocardial infarction). Treatment is not offered unless the vital signs (hypotension and
bradycardia) suggest that the patient is, or may be at risk of, lightheadedness, syncope, or other complications.
Screening ECGs and Holter monitoring may be considered for special patient populations, such as those with
muscular dystrophies (e.g., myotonic dystrophy, Kearns-Sayre's syndrome, peronoeal muscular dystrophy, or
limb-girdle muscular dystrophy), which affect the conduction system of the heart specifically. Findings of bundle-
branch block and fascicular block with bradycardia in these patients, even though asymptomatic, should be
followed-up aggressively because these patients can have unpredictable progression to complete heart block
and sudden death.[35]
Secondary preventionRegular evaluation and examinations are necessary, and patient reporting of
suspicious symptoms is the best way to diagnose problems with bradycardia.Patients should guide practitioners regarding their symptoms and medicinesthat may be associated with bradycardia.
History & examinationKey diagnostic factorshide allpresence of risk factors (common)
Key risk factors include history of taking medicines known to cause bradycardia, age over 70 years,
previous myocardial infarction, surgery, hypothyroidism, sleep apnoea, exposure to toxins,
infections, infiltrative diseases, and electrolyte disorders.pulse rate below 50 bpm (common)
Palpation of peripheral pulse or cardiac auscultation may reveal a slow, regular heart beat of below
50 bpm or an irregular pulse of varying intensity.dizziness/lightheadedness (common)
Occurs owing to bradycardia-induced cerebral hypoperfusion, especially in the setting of left
ventricular dysfunction.syncope (common)
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-35http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-357/27/2019 bradikard
9/186
Syncope is possible with long sinus nodal pauses or very slow heart rates.
Occurs owing to bradycardia-induced cerebral hypoperfusion, especially in the setting of left
ventricular dysfunction.
Common in patients with complete heart block and a very slow ventricular escape rhythm with left
ventricular dysfunction and in patients with second-degree atrioventricular (AV) block.fatigue (common)
Many patients complain of worsening fatigue.
exercise intolerance (common)
May be owing to sinus node, AV node, or His-Purkinje system disease.
shortness of breath (common)
May be owing to sinus node, AV node, or His-Purkinje system disease.
cannon a-waves in jugular venous pulse (common)
Patients with bradycardia secondary to complete heart block can have intermittent cannon a-waves
in their jugular venous pulse noted, owing to atrial contraction against a closed tricuspid valve.
Similarly, there may be a variable S1 during complete AV block.
During a junctional or ventricular rhythm with 1:1 V-to-A conduction, there may be cannon a-waves
for each heart beat.jugular venous distension (common)
Owing to heart failure caused by bradycardia.
Other diagnostic factorshide allincreased intracranial pressure (common)
Sinus bradycardia can be noted as part of Cushing's triad (hypertension, bradycardia, and irregular
respirations) related to raised intracranial pressure.
abnormal heart sounds (uncommon)
Because bradycardia can contribute to heart failure, patients may have a third heart sound and
rales.abdominal or lower extremity oedema (uncommon)
Owing to heart failure caused by bradycardia.
hypotension (uncommon)
Manifestation of poor cardiac output owing to bradycardia.
mental status changes (uncommon)
Manifestation of poor cardiac output owing to bradycardia.
pallor(uncommon)
Manifestation of poor cardiac output owing to bradycardia.
extremities cool to touch (uncommon)
Manifestation of poor cardiac output owing to bradycardia.
hypothermia (uncommon)
Asymptomatic or symptomatic sinus bradycardia may occur in association with hypothermia.
chest pain (uncommon)
Rare presentation of bradycardia.
7/27/2019 bradikard
10/186
Risk factorshide all
Strong
use of known causative medications
Class I antiarrythmics (sodium channel blockers such as quinidine, disopyramide, lidocaine,
phenytoin, fleicanide, propafenone), class III antiarrhythmics (potassium channel blockers such as
amiodarone, sotalol, dofetilide), digoxin, beta-blockers, and calcium-channel blockers can cause
bradycardia.[3] The effect is often dose- and drug-level-dependent, which, in turn, will depend on
factors affecting drug metabolism, such as patient age, renal function, and hepatic function.
Other non-cardiac medicines that can cause bradycardia include: clonidine, calcium chloride,
calcium gluconate, lithium, reserpine, methyldopa, opioids, benzatropine, paclitaxel, topical
ophthalmic beta-blockers, phenytoin, cimetidine, thalidomide, dimethyl sulphoxide, topical
ophthalmic acetylcholine, fentanyl, alfentanil, sufentanil, and cholinesterase inhibitors.
Drugs that contribute to atrioventricular (AV) block and/or sinus node dysfunction may only be
uncovering an underlying 'occult' problem.[17]age over 70 years
Older patients are at greater risk for developing sinus node dysfunction and AV nodal disease,
which are the major causes of bradycardia in this patient cohort.
In general, bradycardia is related to degeneration of the conduction system and the sinus node and
changes in autonomic tone, which tends to worsen with age.[9][18] [19] [20]recent myocardial infarction
Acute myocardial infarction can cause bradycardia by causing conduction block in the AV node
(inferior infarction) or the His-Purkinje system (anterior infarction).[3] [21] [22] [23] Sinus bradycardia and AV block owing to inferior infarction is often caused by the Bezold-Jarisch
reflex (i.e., a transient increased vagal activation). Consequently, bradycardia following inferior
infarction often resolves. Generally, the bradycardia caused by AV block in the His-Purkinje system
owing to anterior wall myocardial infarction does not resolve.
Acute thrombosis of a coronary artery supplying the sinus or AV node can cause bradycardia,
although permanent AV block is generally caused by anterior infarction affecting the bundle of His.
Common causes for sinus bradycardia and AV block in the setting of acute myocardial infarction
include the use of beta-blockers, calcium-channel blockers, antiarrhythmics, and morphine; high
levels of pain; increased vagal tone (especially following inferior infarction); and atrial ischaemia.surgery
Sinus bradycardia is common intra-operatively owing to manoeuvres that increase vagal tone, such
as intubation. If intra-operative hypothermia is planned, sinus bradycardia will almost certainly
occur. It may also occur after hydrogen peroxide irrigation during neurosurgery.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-23http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-23http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-17http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-9http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-18http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-19http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-20http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-21http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-22http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-237/27/2019 bradikard
11/186
Sinus bradycardia is also common postoperatively, mainly owing to pain, use of opioids, or the
effects of the surgery itself.
Bradycardia can be due to injury to the sinus node during heart-transplant surgery. Sinus node
disease can become apparent after a Mustard procedure for transposition of the great arteries and
repair of an atrial septal defect.
AV block can occur after mitral valve and/or aortic valve surgery and after ventricular septal defect
repair.hypothyroidism
Sinus bradycardia is usually noted in patients with significant hypothyroidism, whether or not they
have other symptoms of the disease, including signs and symptoms of congestive heart failure.[3]electrolyte disorders
Hyperkalaemia, hypokalaemia, hypercalcaemia, and hypocalcaemia can cause bradycardia.
Hyperkalaemia tends to be the most common abnormality seen; it causes bradycardia by causing a
sinoventricular rhythm or AV block.[3]
Should be screened for in all patients with bradycardia because they are easily correctable.
infections
Typhoid fever, diphtheria, tuberculosis, toxoplasmosis, rheumatic fever, viral myocarditis and Lyme
disease have all been associated with bradycardia.exposure to toxins
Lead exposure, black widow spider venom, and tricyclic antidepressant overdose have all been
associated with bradycardia.infiltrative diseases
Infiltrative disease, such as amyloidosis, Chagas' disease, or haemochromatosis, may also affect
the conduction system of the heart, causing bradycardia.sleep apnoea
Sinus node arrest, sinus bradycardia, and second-degree AV block are all manifestations of sleep
apnoea.
Diagnostic tests1st tests to ordershow all
Test Result
12-lead ECG may show sinus bradycardia with or without sinu
block with junctional or ventricular escape, His-and AV block in a setting of myocardial infarcti
precordium indicative of a neurological event m
bradycardia
Holter monitoring sinus pauses; sinus arrest; second- or third-degrewith symptoms
event monitor sinus pauses; sinus arrest; second- or third-degrewith symptoms
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-3http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37/27/2019 bradikard
12/186
exercise testing exercise-induced AV block; chronotropic incom
carotid sinus massage pause of over 3 seconds with symptoms suggestof carotid sinus hypersensitivity
echocardiogram underlying structural heart disease, such as ventrdisease
thyroid function tests elevated TSH in hypothyroidism
basic metabolic panel hypokalaemia or hyperkalaemia; hypocalcaemia
cardiac markers elevation of CK, CK-MB, and troponin in myoc
serum digoxin level depends on dose and drug-metabolism factors; m
serum creatinine elevated
Tests to considerhide all
Test
implantable-loop recorder
Subcutaneous monitoring device used for the detection of cardiac arrhythmias.
Typically implanted in the left parasternal or pectoral region.
Useful modality if a patient has intermittent symptoms suspected to be secondary to a bradyarrhythmia b
ECG abnormalities and negative Holter and/or event monitoring. Safe and efficacious in these settings.
Device is implanted by an electrophysiologist and can be used for monitoring for up to 18 months.
Stores recorded ECG strips either when the device is activated by the patient or when activated automa
according to programmed threshold criteria. Periodic interrogation of the device can retrieve this informa
Also useful to rule out bradyarrhythmia as a cause of the patient's symptoms by identifying normal sinus
time of a symptom event of interest.
Reduce/prevent recurrent symptoms.[29]
May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or tachy
syndrome) is suspected but cannot be documented.
Particularly useful in diagnosing Mobitz I AV block.
tilt-table testing
Used to evaluate the adequacy of the autonomic system, especially when there is suspicion of neurocar
syncope. Commonly used method is head-upright tilting, which causes dependent venous pooling and th
provokes the autonomic response.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-297/27/2019 bradikard
13/186
electrophysiology testing
Recommended when symptoms cannot be correlated clearly and when significant bradyarrhythmias are
cannot be diagnosed by non-invasive modalities.
Testing can be useful in patients with AV block and no clear symptom association; in patients with symp
bradycardia and in whom AV block is suspected but not documented; and when the site of AV block candetermined reliably by surface tracings.
His-ventricle interval of >100 milliseconds in a patient with bradycardia, even in the absence of symptom
risk finding.[31] [32]
Overall, the role of electrophysiological testing for bradycardia is limited, owing to low sensitivity and spe
Positive findings may not be the reason for symptoms.[33] [34]
May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or tachy
syndrome) is suspected but cannot be documented.
Atrial pacing progressively shorter cycle lengths during an electrophysiology study can manifest Mobitz t
subjects with normal or abnormal AV node conduction.
Asymptomatic patients with Mobitz II AV block may benefit from this test to localise the site of block and
therapy.
Useful to demonstrate the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and hig
block.
Differential diagnosisCondition
Differentiating
signs/symptoms Differentiating tests
Ventricular bigeminy Post-
premature
ventricular
contraction
(PVC)
potentiation
not present
during sinus
rhythm
without PVCs.
Cannon a-
waves seen in
ECG and rhythm strip correlated with pulse show a
each normal beat.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-347/27/2019 bradikard
14/186
the jugular
venous pulse.
Frequent premature ventricular
contractions (PVCs) Non-perfused
ventricularectopy
causing
apparent
sinus
bradycardia.
Patients are
usually
asymptomatic
.
Cannon a-
waves may be
seen in the
jugular
venous pulse.
ECG and rhythm strip correlated with pulse. Specif
cause. However, ventricular beats occur earlier tha
Atrial fibrillation Apical versus
peripheral
pulse.
Irregular pulse
rate.
ECG shows absent P waves, presence of fibrillator
complexes. Rhythm strip may be useful.
Blocked premature atrial
contractions (PACs) Atrial rate is
fast but
ventricular
rate is slow.
ECG shows slight notching on preceding T-wave.
Ventricular tachycardia A-waves,
variable S1,
and variable
pulse seen in
ECG shows atrioventricular (AV) dissociation with c
http://bestpractice.bmj.com/best-practice/monograph/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/537.htmlhttp://bestpractice.bmj.com/best-practice/monograph/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/537.html7/27/2019 bradikard
15/186
jugular
venous
pressure.
Cardiac tamponade
Muffled heartsounds.
Sinus
tachycardia.
Pulsus
paradoxus
(usually below
10 mmHg).
Elevated
jugular
venous
pressure.
ECG shows low voltage, QRS, or total electrical alt
Echocardiogram shows large pericardial effusion o
respiratory variation of ventricular filling.
Step-by-step diagnostic approachA diagnosis of bradycardia is simple and is generally made on an ECG or
telemetry monitor when there is slowing of the heart rhythm to below 50 bpm,even if only transient. The challenge is determining the aetiology of thebradycardia and determining the site at which there is reduction in impulsegeneration or propagation. The primary use of testing is to correlatesymptoms with bradycardia and/or to establish a potentially dangerouscondition as the cause of bradycardia, even though the patient may beasymptomatic.
History
The most important diagnostic factor is age. Older patients present frequentlywith bradycardia owing to disease in the sinus node, the atrioventricular (AV)node, or the His-Purkinje system. In the AV conduction system, age-relatedfibrosis and sclerosis (Lenegre-Lev's disease) account for AV block in almosthalf of the cases. Older patients in particular may also present withbradycardia associated with medicines that have AV-node-blockingproperties, such as beta-blockers, calcium-channel blockers, and digoxin;therefore, a detailed drug history should be taken.
http://bestpractice.bmj.com/best-practice/monograph/459.htmlhttp://bestpractice.bmj.com/best-practice/monograph/459.html7/27/2019 bradikard
16/186
A history of infection, infiltrative diseases, increased intracranial pressure,electrolyte disorders, exposure to toxins, surgery, heart transplant, sleepapnoea, or myocardial infarction may be present. Sinus bradycardia is usuallynoted in patients with significant hypothyroidism, whether or not they haveother symptoms of the disease. Asymptomatic or symptomatic sinus
bradycardia may occur in association with hypothermia.
One of the most common symptoms associated with bradycardia is dizzinessor lightheadedness. Many patients also complain of worsening fatigue.Syncope is possible with long pauses or slow heart rates, especially inpatients with complete heart block and a slow ventricular escape rhythm withleft ventricular dysfunction or in patients with second-degree AV block. Thesesymptoms generally occur owing to bradycardia-induced cerebralhypoperfusion, especially in the setting of left ventricular dysfunction.Exercise intolerance and shortness of breath is also common and may bedue to sinus node, AV node, or His-Purkinje system disease. Chest pain is arare presentation. Bradycardia can be asymptomatic, especially in youngerindividuals.
Physical examinationExamination is usually non-specific. Palpation of peripheral pulse or cardiacauscultation may reveal a slow, regular heart beat of below 50 bpm or anirregular pulse of varying intensity.
Patients with bradycardia secondary to complete heart block can haveintermittent cannon a-waves in their jugular venous pulse (JVP) owing toatrial contraction against a closed tricuspid valve. Similarly, there may be avariable S1 during complete AV block. During a junctional or ventricularrhythm with 1:1 V-to-A conduction, there may be cannon a-waves for eachheart beat.
Because bradycardia can contribute to heart failure, patients may have a thirdheart sound, rales, jugular venous distension, and abdominal and lower
extremity oedema. Signs of hypothyroidism should be assessed (e.g., dry orcoarse skin or hair, facial oedema). Poor cardiac output due to bradycardiamay be manifest as hypotension, mental status changes, and/or pallor; theextremities may be cool to the touch.
ECG
7/27/2019 bradikard
17/186
A 12-lead ECG is the first test in the diagnosis of bradycardia, regardless ofthe suspected cause. It is simple and easy to perform and providesdiagnostic information. ECG also offers important clues regarding underlyingconditions that could have caused the bradycardia; however, it only gives asnapshot in time that may not be helpful for diagnosis if bradycardia or
symptoms are intermittent. In this situation, ambulatory monitoring is neededto correlate symptoms to bradycardia. ECG result depends on the cause ofbradycardia.
Sinus node dysfunction
Sinus bradycardia: regular P-wave followed by QRS at a rate of below 50 bpm; ambulatory ECG
monitoring is helpful to correlate symptoms with heart rate.
Sinus nodal pauses or arrest: long RR cycle length, which is longer than the RR interval of the
underlying sinus rhythm. View image
Sinus nodal exit block: an absent P-wave and prolongation of the RR cycle length, usually twice the
underlying sinus RR interval.
Tachy-brady syndrome: episodic periods of tachycardia (usually atrial flutter, atrial fibrillation, or atrial
tachycardia), followed by termination of the tachycardia leading to sinus arrest or long sinus pauses, followed by
sinus bradycardia.View imageView imageView imageView image
AV conduction disturbance
First-degree AV block: fixed prolongation of the PR interval over 0.2 seconds.[10] View image Second-degree AV block:
o Mobitz I: grouped beating with a constant PP interval, lengthening in the PR interval and
changing (usually shortening) RR intervals with the cycle ending with a P-wave not followed by a QRS complex.
As the PR interval gradually prolongs, the RR interval tends to stay the same or shorten.[11] View imageView
imageView image
o Mobitz II: associated with single non-conducted P-waves with a constant PP interval and
constant PR intervals (no change in the PR of over 0.025 seconds).[12] View imageView image
o 2:1 AV block: only one PR interval to examine before the blocked P-wave and 2 P-waves for
every QRS complex.View imageView image Block can be at the level of the AV node or the His-Purkinje system.
If the QRS is narrow, the level of the block is probably in the AV node (which is more benign). If the QRS is wide
(owing to bundle branch block or other conduction delay), block in the AV node is still most common but block in
the His-Purkinje system is more frequent than when the QRS complex is narrow.
o High-degree: more than one sequentially blocked P-wave. Block can be at the level of the AV
node or the His-Purkinje system, as is the case with 2:1 AV block.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/1.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/4.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/5.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/6.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/7.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/9.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/11.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/13.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/14.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/1.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/4.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/5.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/6.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/7.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-10http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/9.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-11http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/10.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/12.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/11.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-12http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/8.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/15.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/13.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/14.html7/27/2019 bradikard
18/186
Third-degree AV block: occurs when there are no conducted impulses from the atria to the ventricles;
shows no consistent PR relationship.View imageView image May occur with ventricular or junctional escape
rhythm.View imageView imageView image
Paroxysmal AV block: normal AV nodal conduction followed by sudden block of AV conduction
associated with a long pause and multiple blocked P-waves, with subsequent resumption of AV conduction.
Vagotonic AV block: slowing of the sinus node with prolongation of the PR interval followed by AV block
owing to transient abrupt increase in parasympathetic tone.
Congenital complete heart block: usually associated with a narrow QRS complex escape rhythm arising
in the AV node.
Escape rhythms may also occur in AV block, such as atrial (abnormal P-wave and decreased PR
interval), junctional (above the bundle of His, produces a rate of approximately 40 to 60 bpm and narrow QRS
complexes) View imageand ventricular rhythms (below the bundle of His, produces a slower rate of 20 to 40
bpm and wide QRS complexes).
AV dissociation
Independent activation of the atria and ventricles results in no fixedrelationship between the P-waves and the QRS complexes. The PR intervalsare variable in a random fashion. Ventricular rate is the same or faster thanthe atrial rate. There are 2 types:
Isorhythmic: when the atrial rate is the same (or nearly the same as the ventricular rate) but the P-wave
is not conducted.
Interference: when P-waves and QRS rates are similar but, occasionally, the atria conduct to the
ventricles.View imageView image
Laboratory investigationsThere are no specific laboratory investigations used to diagnose bradycardia;however, initial work-up should include thyroid function tests and a completemetabolic panel to rule out electrolyte disturbances, particularly
hyperkalaemia, hypokalaemia, hypercalcaemia, and hypocalcaemia. Cardiacenzymes should be obtained if bradycardia is associated with ECG changessuggestive of myocardial infarction or ischaemia. Patients who have
junctional bradycardia and who are prescribed digoxin should have theirserum digoxin level checked. Patients with chronic bradycardia may haveevidence of worsening renal function. Any additional laboratory testing shouldbe guided by information obtained by history and physical examination to aididentification of the underlying cause.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/16.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/17.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/18.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/19.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/2.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/21.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/16.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/17.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/18.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/19.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/2.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/3.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/20.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/resources/images/print/21.html7/27/2019 bradikard
19/186
Other initial investigationsHolter or event monitoring, exercise testing, carotid sinus massage, andechocardiogram all form part of the initial work-up in addition to the ECG andare especially useful for intermittent bradycardia or patients with symptoms. Ifpatients have sinus bradycardia, they should be further evaluated only if theyare symptomatic or show evidence of haemodynamic compromise.
Holter monitoring
Enables correlation of symptoms with episodes of bradycardia. Diagnostic clues are obtained in 50% to
70% of patients with bradycardia suspected on clinical grounds.[24] [25]However, events can be missed if
symptoms do not occur in the 24- to 48-hour monitoring period.
Asymptomatic bradycardia and pauses (especially nocturnal) are not uncommon in the normal heart and
are probably non-diagnostic.
Shows sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia with
symptoms. First-degree AV block or Mobitz type I AV block may be noted while patients are asleep owing to high
vagal tone.
May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or
tachy-brady syndrome) is suspected but cannot be documented.
May help distinguish the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and high-
degree AV block. A long-monitored strip should be run because 2:1 AV block is unlikely to persist. The other
forms of AV block (Mobitz I or II) should then become apparent. Monitoring while the patient does some form of
exertion (e.g., arm exercise, standing, and walking) may also help to demonstrate the level of block. Block at the
level of the AV node should improve with the adrenergic stimulation but block below the AV node in the His-
Purkinje system may worsen as AV nodal conduction improves and increases the frequency of inputs to the His-
Purkinje system.
Event monitoring
Widely used in the diagnosis of symptomatic bradycardia and can be worn for up to 30 days.
Earlier designs were patient-triggered and so relied on the patient being able to recognise their
symptoms and activate the monitor in a timely manner. This issue has been corrected to some extent by newer-
generation monitors with auto-triggering capability and implantable loop recorders.
Shows sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia with
symptoms. May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, or
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-25http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-25http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-257/27/2019 bradikard
20/186
tachy-brady syndrome) is suspected but cannot be documented. Particularly useful in diagnosing Mobitz I AV
block.
Exercise testing
A sub-normal increase in heart rate after exercise (chronotropic incompetence) can be useful in
diagnosing sick sinus syndrome.[24] [26] However, sensitivity and specificity are unclear and the results
obtained may not be reproducible.[27] Even so, exercise-induced AV block, even if asymptomatic, can be
significant and suggests disease of the His-Purkinje system.
Identifying symptoms owing to sinus bradycardia can be difficult; however, exercise testing can be useful
to help determine sinus node dysfunction as the cause of symptoms.
Useful in determining level of block in Mobitz I.
Carotid sinus massage
Used during continuous ECG monitoring (after evaluating for the presence of carotid bruit by direct
auscultation) in the evaluation of carotid sinus hypersensitivity, which causes symptomatic bradycardia and is
associated with sick sinus syndrome.
Diagnostic yield of carotid sinus massage can be increased by performing this during head-up
tilting.[28]
A pause of over 3 seconds with symptoms is indicative of a cardio-inhibitory response from carotid sinus
hypersensitivity.
Can help diagnose Mobitz I and II AV block; it will accentuate Wenckebach in the AV node but will have
an opposite effect if the block is below the His bundle.
May help distinguish the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and high-
degree AV block. It may improve block in the His-Purkinje system by slowing the sinus and AV nodal inputs to
the His-Purkinje system, enabling the His-Purkinje system longer in which to recover between inputs.
Echocardiogram
Although it provides no direct diagnostic role for bradycardia, it provides valuable information regarding
underlying heart disease that can influence management and decision making.Patients with significantly reduced
left ventricular systolic function should be considered for an implantable cardioverter defibrillator if clinically
appropriate.
Further investigationsImplantable loop monitor
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-28http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-24http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-26http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-27http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-287/27/2019 bradikard
21/186
A subcutaneous monitoring device used for the detection of cardiac arrhythmias. Typically implanted in
the left parasternal or pectoral region.
Useful modality if a patient has rare symptoms that are difficult to record with non-invasive tools such as
ECG, Holter monitors, and/or event monitors due to their infrequent nature, but are suspected to be secondary to
a bradyarrhythmia. Safe and efficacious in these settings.[29] [30] Also useful to rule out bradyarrhythmia as a cause of symptoms by identifying normal sinus rhythm at
the time of a symptom event of interest.
May show sinus pauses, sinus arrest, second- or third-degree AV block, or severe sinus bradycardia
with symptoms. May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest,
or tachy-brady syndrome) is suspected but cannot be documented. Particularly useful in diagnosing Mobitz I AV
block.
Tilt-table testing
Used to evaluate adequacy of the autonomic system, especially when there is suspicion of
neurocardiogenic syncope.
A commonly used method is head-upright tilting, which causes dependent venous pooling and thereby
provokes the autonomic response.
Electrophysiological testing
Recommended when symptoms cannot be correlated clearly and when significant bradyarrhythmias are
suspected but cannot be diagnosed by non-invasive modalities.
Electrophysiological measurements of sinus node function serve only as an adjunct to clinical and non-
invasive parameters because these tests are based on assumptions that limit their validity and clinical utility.
There is little utility for electrophysiology testing in already-documented second- and third-degree AV
block. Testing can be useful in patients with AV block and no clear symptom association; in patients with
symptoms of bradycardia in whom AV block is suspected but not documented; and when the site of AV block
cannot be determined reliably by surface tracings.
His-ventricle interval of over 100 milliseconds in a patient with bradycardia, even in the absence of
symptoms, is a high-risk finding.[31] [32]
Overall, the role of electrophysiological testing for bradycardia is limited, owing to low sensitivity and
specificity. Positive findings may not be the reason for patient symptoms.[33][34]
May be used if severe sinus node dysfunction (e.g., sinus exit block, sinus pauses, sinus arrest, tachy-
brady syndrome) is suspected but cannot be documented.
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-34http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-29http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-30http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-31http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-32http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-33http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-347/27/2019 bradikard
22/186
Atrial pacing at progressively shorter cycle lengths during an electrophysiology study can manifest
Mobitz type I in subjects with normal or abnormal AV node conduction.
Asymptomatic patients with Mobitz II AV block may benefit from this test to localise the site of block and
to guide therapy.
Useful to demonstrate the location of the block (i.e., AV node versus His-Purkinje system) in 2:1 and
high-degree AV block.
Click to view diagnostic guideline references. Case history #1An 85-year-old man presents with fatigue and episodes during which he feelshe is going to pass out. He has no known heart disease. His ECG showssinus bradycardia with a rate of 30 bpm and on a rhythm strip he has up to 5-second pauses.
Case history #2A 55-year-old man with hypertension and diabetes presents at theemergency department with complaints of dizziness and lightheadedness onexertion that has occurred gradually over the past month. He takesmetoprolol (a beta-blocker) for hypertension. He is hypotensive and has aheart rate of 45 bpm. The rhythm strip shows Mobitz type II atrioventricular(AV) block with Q waves in the inferior leads. There are no previous ECGs.
Other presentationsOther diagnostic features include exercise intolerance and chest pain.
Atypical presentations include elite athletes who present with sinusbradycardia, Mobitz I, or even Mobitz II atrioventricular (AV) block withoutsymptoms owing to a conditioned heart. The condition could also manifestshortly after taking a beta-blocker, calcium-channel blocker, or digoxin in apatient with conduction system disease. Adolescents may not have anysymptoms owing to preserved left-ventricular function; by contrast, older
people are more likely to manifest symptoms because of structural heartdisease.
Treatment Options
http://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.htmlhttp://bestpractice.bmj.com/best-practice/monograph/832/diagnosis/guidelines.html7/27/2019 bradikard
23/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine: 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine: 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
2nd temporary pacing
Patients who are not responsive to medical
http://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-6&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-4&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-5&optionId=expsec-1&dd=MARTINDALEhttp://bestpractice.bmj.com/best-practice/druglink.html?component-id=297624-6&optionId=expsec-1&dd=MARTINDALE7/27/2019 bradikard
24/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine.All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
haemodynamically stable: sinus
http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-37http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-36http://bestpractice.bmj.com/best-practice/monograph/832/resources/references.html#ref-377/27/2019 bradikard
25/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
node dysfunction
7/27/2019 bradikard
26/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
reversible cause: asymptomatic or1st treatment of underlying cause
7/27/2019 bradikard
27/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
mild symptoms For mild symptoms or when sinus node
7/27/2019 bradikard
28/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
dysfunction is a result of a reversible or isolated
7/27/2019 bradikard
29/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
cause (e.g., specific medicine, electrolyte disorder,
7/27/2019 bradikard
30/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmacotherapy
In patients with systemic hypotension, signs of
cerebral hypoperfusion, progressive heart failure,
angina, or life-threatening ventricular
tachyarrhythmia, medical therapy should be
started immediately until temporary cardiac pacing
is initiated.
The most common medicines used to increase
ventricular rate are intravenous atropine,
epinephrine (adrenaline), or dopamine. All drugs
are only marginally effective in providing sustained
chronotropic support.
Their efficacy is limited to patients with sinus node
dysfunction or conduction abnormalities at the
level of the atrioventricular (AV) node. However,
patients with infranodal conduction system
disease may demonstrate further worsening
bradycardia.
Dopamine should not be used in patients with life-
threatening tachyarrhythmias and should be usedwith caution in patients with ischaemic heart
disease.
Primary Options
atropine : 0.5 to 1 mg intravenously as a bolus,
repeat every 3-5 minutes as needed, maximum 3
mg total dose
Secondary Options
epinephrine : 2-10 micrograms/min intravenous
infusion, titrate rate according to response
OR
dopamine : 2-10 micrograms/kg/min intravenous
infusion, titrate rate according to response
or vasovagal event, such as taking blood),
7/27/2019 bradikard
31/186
Patient group
Treatment
line Treatmenthide all
haemodynamically unstable1st pharmac